v3.0.7
Please consider this website is continuously evolving and still under development
to harmonize automatic data extraction and integrate manual data annotation.
Column | Value |
---|---|
Trial registration number | NCT04627519 |
Full text link
Last imported at : Nov. 14, 2020, 11:31 p.m. Source : ClinicalTrials.gov |
|
First author
Last imported at : June 12, 2021, 12:32 a.m. Source : ClinicalTrials.gov |
|
Contact
Last imported at : June 12, 2021, 12:32 a.m. Source : ClinicalTrials.gov |
lestarikd@unpad.ac.id |
Registration date
Last imported at : Nov. 14, 2020, 11:31 p.m. Source : ClinicalTrials.gov |
2020-11-13 |
Recruitment status
Last imported at : June 5, 2023, 8 a.m. Source : ClinicalTrials.gov |
Unknown |
Study design
Last imported at : Nov. 14, 2020, 11:31 p.m. Source : ClinicalTrials.gov |
RCT |
Allocation
Last imported at : Nov. 14, 2020, 11:31 p.m. Source : ClinicalTrials.gov |
Randomized |
Design
Last imported at : Nov. 14, 2020, 11:31 p.m. Source : ClinicalTrials.gov |
Parallel |
Masking
Last imported at : Nov. 14, 2020, 11:31 p.m. Source : ClinicalTrials.gov |
Open label |
Center
Last imported at : Nov. 14, 2020, 11:31 p.m. Source : ClinicalTrials.gov |
multi-center |
Study aim
Last imported at : Nov. 14, 2020, 11:31 p.m. Source : ClinicalTrials.gov |
Treatment |
Inclusion criteria
Last imported at : Nov. 16, 2021, 6:30 p.m. Source : ClinicalTrials.gov |
inclusion criteria: male and female patients aged ≥ 18 years to 50 years old, who recently admitted as in-patients and have not received any standard of care yet, with covid-19 confirmed by pcr with mild to moderate symptoms. female subjects of child-bearing age agree to take effective contraceptive measures during the study until seven days of the last oral medication of study product; willing to receive a random assignment to any designated treatment group and not participating in another study at the same time; willing for not using any other immunomodulator or treatment that might bias the study patient willing to provide informed consent. |
Exclusion criteria
Last imported at : Nov. 16, 2021, 6:30 p.m. Source : ClinicalTrials.gov |
any allergy to any composition of rhea health tone®; pregnant and breastfeeding; history and co-morbid of severe underlying disease where treatment and follow up is not likely to be beneficial to the patient based on physician judgment (e.g. retinopathy, cardiovascular disease (qtc > 500 mdet (narrow qrs); qtc ≥ 550 mdet (wide qrs)), heart arrhythmia, uncontrolled diabetes mellitus, hypertension, chronic pulmonary disease, asthma, chronic kidney disease (creatinine > 2x upper limit of normal), liver disease (sgot/sgpt > 2x limit of normal), chronic neurological disease, or etc.). this includes people requiring care in designated supported living facilities and severe dementia; possibility of being transferred to a non-study-hospital within 72 hours. history of autoimmune disease, cancer, hiv aids. |
Number of arms
Last imported at : Nov. 14, 2020, 11:31 p.m. Source : ClinicalTrials.gov |
2 |
Funding
Last imported at : Nov. 14, 2020, 11:31 p.m. Source : ClinicalTrials.gov |
Universitas Padjadjaran |
Inclusion age min
Last imported at : Nov. 14, 2020, 11:31 p.m. Source : ClinicalTrials.gov |
18 |
Inclusion age max
Last imported at : Nov. 14, 2020, 11:31 p.m. Source : ClinicalTrials.gov |
50 |
Countries
Last imported at : Feb. 11, 2021, 12:31 a.m. Source : ClinicalTrials.gov |
Indonesia |
Type of patients
Last imported at : Nov. 14, 2020, 11:31 p.m. Source : ClinicalTrials.gov |
Mild/moderate disease at enrollment |
Severity scale
Last imported at : Nov. 14, 2020, 11:31 p.m. Source : ClinicalTrials.gov |
2: Mild/moderate disease at enrollment |
Total sample size
Last imported at : Feb. 11, 2021, 12:31 a.m. Source : ClinicalTrials.gov |
85 |
primary outcome
Last imported at : Nov. 14, 2020, 11:31 p.m. Source : ClinicalTrials.gov |
Length of stay |
Notes
Last imported at : Nov. 14, 2020, 11:31 p.m. Source : ClinicalTrials.gov |
None |
Phase
Last imported at : Nov. 16, 2021, 6:30 p.m. Source : ClinicalTrials.gov |
Phase 2 |
Arms
Last imported at : Nov. 14, 2020, 11:31 p.m. Source : ClinicalTrials.gov |
[{"arm_notes": "", "treatment_id": 93, "treatment_name": "Antioxidant therapy", "treatment_type": "Others pharmacological treatment", "pharmacological_treatment": "Pharmacological treatment"}, {"arm_notes": "", "treatment_id": 2188, "treatment_name": "Standard of care", "treatment_type": "Standard of care", "pharmacological_treatment": "Standard of care"}] |